Wnt antagonist gene polymorphisms and renal cancer

Cancer

Volumn 115, Issue 19, 2009, Pages 4488-4503

  Hirata, Hiroshi ^a   Hinoda, Yuji ^b   Nakajima, Koichi ^c   Kikuno, Nobuyuki ^a   Yamamura, Soichiro ^a   Kawakami, Kazumori ^a   Suehiro, Yutaka ^b   Tabatabai, Z Laura ^a   Ishii, Nobuhisa ^c   Dahiya, Rajvir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOHO UNIVERSITY   (Japan)

Author keywords

Dickkopf; Polymorphism; Renal cell carcinoma; Secreted frizzled related protein; Wingless type mouse mammary tumor virus integration site

Indexed keywords

ADENINE; CYTARABINE; GUANINE; SECRETED FRIZZLED RELATED PROTEIN 4; SMAD7 PROTEIN; THYMINE; WNT PROTEIN;

ADULT; ARTICLE; BREAST TUMOR; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CODON; CONTROLLED STUDY; DAMM2 GENE; DICKKOPF 2 GENE; DISTANT METASTASIS; DKK3 GENE; DKK4 GENE; DNA POLYMORPHISM; FEMALE; GENE; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; KIDNEY CANCER; KIDNEY CARCINOMA; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MORPHOGENESIS; NEPHRECTOMY; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SECRETED FRIZZLED RELATED PROTEIN 4 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMAD7 GENE;

ANIMALS; BETA CATENIN; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY NEOPLASMS; MALE; MICE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; WNT PROTEINS;

EID: 70349274435     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24491     Document Type: Article

References (50)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics. 2000. CA Cancer J Clin. 2004;50:7-33.
2. Eggener SE, Yossepowitch O, Pettus JA, Snyder ME, Motzer RJ, Russo P. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. J Clin Oncol. 2006;24:3101-3106. (Pubitemid 46638947)
3. Kudo-Saito C, Wansley EK, Gruys ME, Wiltrout R, Schlom J, Hodge JW. Combination therapy of an orthotopic renal cell carcinoma model using intratumoral vector-mediated costimulation and systemic interleukin-2. Clin Cancer Res. 2007;13:1936-1946. (Pubitemid 46957365)
4. Niehrs C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene. 2006;25:7469-7481. (Pubitemid 44885746)
5. Katoh M, Katoh M. WNT signaling pathway and stem cell signaling network. Clin Cancer Res. 2007;13:4042-4405
6. Lu X, Borchers AG, Jolicoeur C, Rayburn H, Baker JC, Tessier-Lavigne M. PTK7/CKK-4 is a novel regulatr of planar cell polarity in vertebrates. Nature. 2004;430:93-98. (Pubitemid 38915231)
7. Lu W, Yamamoto V, Ortega B, Baltimore D. Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth. Cell. 2004;119:97-108. (Pubitemid 39349323)
8. Kawano Y, Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci. 2003;116:2627-2634. (Pubitemid 36857216)
9. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113:685-700. (Pubitemid 36724933)
10. Barker N, Morin PJ, Clevers H. The Yin-Yang of TCF/beta-catenin signaling. Adv Cancer Res. 2000;77:1-24.
11. Edlund S, Lee SY, Grimsby S, et al. Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis. Mol Cell Biol. 2005;25:1475-1488. (Pubitemid 40204923)
12. Urakami S, Shiina H, Enokida H, et al. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. Clin Cancer Res. 2006;12:6989-6997. (Pubitemid 44974494)
13. Dahl E, Wiesmann F, Woenckhaus M, et al. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma. Oncogene. 2007;26:5680-5691. (Pubitemid 47267837)
14. Gumz ML, Zou H, Kreinest PA, et al. Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res. 2007;13:4740-4749. (Pubitemid 47294780)
15. Kawamoto K, Hirata H, Kikuno N, Tanaka Y, Nakagawa M, Dahiya R. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Int J Cancer. 2008;123:535-542. (Pubitemid 351898410)
16. Shiina H, Igawa M, Breault J, et al. The human T-cell factor- 4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. Clin Cancer Res. 2003;9:2121-2132.
17. Frank B, Burwinkel B, Bermejo JL, et al. Ten recently identified associations between nsSNPs and colorectal cancer could not be replicated in German families. Cancer Lett. 2008;271:153-157.
18. Proitsi P, Li T, Hamilton G, et al. Positional pathway screen of wnt signaling genes in schizophrenia: association with DKK4. Biol Psychiatry. 2008;63:13-16. (Pubitemid 350234884)
19. Tanaka Y, Hiroshi H, Zhong C, et al. Polymorphisms of catechol-O-methyltransferase in men with renal cell cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:92-97. (Pubitemid 46174269)
20. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med. 1990;9:811-818. (Pubitemid 20343989)
21. Xie Y, Pan W, Khodursky AB. A note on using permutation- based false discovery rate estimates to compare different analysis methods for microarray data. Bioinformatics. 2005;21:4280-4288. (Pubitemid 41724308)
22. Kurose K, Sakaguchi M, Nasu Y, et al. Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma. J Urol. 2004;171:1314-1318. (Pubitemid 38327602)
23. Hsieh SY, Hsieh PS, Chiu CT, Chen WY. Dickkopf-3/REIC functions as a suppressor gene of tumor growth. Oncogene. 2004;23:9183-9189. (Pubitemid 40069688)
24. Kuphal S, Lodermeyer S, Bataille F, Schuierer M, Hoang BH, Bosserhoff AK. Expression of Dickkopf genes is strongly reduced in malignant melanoma. Oncogene. 2006;25:5027-5036. (Pubitemid 44246361)
25. Kobayashia K, Ouchida M, Tsuji T, et al. Reduced expression of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor cells. Gene. 2002;282:151-158. (Pubitemid 34117571)
26. Suzuki H, Toyota M, Caraway H, et al. Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer. 2008;98:1147-1156. (Pubitemid 351958902)
27. Sato H, Suzuki H, Toyota1 M, et al. Frequent epigenetic inactivation of Dickkopf family genes in human gastrointestinal tumors. Carcinogenesis. 2007;28:2459-2466. (Pubitemid 350238947)
28. Roman-Gomez J, Jimenez-Velasco A, Catillejo JA, et al. Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor on acute lymphoblastic leukemia. Blood. 2004;104:2492-2498. (Pubitemid 39331852)
29. Aguilera O, Fraga MF, Ballestar E, et al. Epigenetic inactivation of the Wnt antagonist Dickkopf-1 (DKK-1) gene in human colorectal cancer. Oncogene. 2006;25:4116-4121. (Pubitemid 44024874)
30. Urakami S, Shiina H, Enokida H, et al. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin Cancer Res. 2006;12:2109-2116.
31. Zenzmaier C, Untergasser G, Hermann M, Dirnhofer S, Sampson N, Berger P. Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue. Prostate. 2008;68:540-547.
32. Yue W, Sun Q, Dacic S, et al. Downregulation of Dkk3 activates β-catenin/TCF-4 signaling in lung cancer. Carcinogenesis. 2008;29:84-92. (Pubitemid 351201745)
33. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004;432:324-331. (Pubitemid 39551660)
34. Tse KP, Tsang NM, Chen KD, et al. MCP-1 promoter polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment. Clin Cancer Res. 2007;13:6320-6326.
35. Mao B, Wu W, Davidson G, et al. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signaling. Nature. 2002;417:664-667. (Pubitemid 34614827)
36. Mao B, Niehrs C. Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling. Gene. 2003;302:179-183. (Pubitemid 36078410)
37. Chim CS, Pang R, Fung TK, Choi CL, Liang R. Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma. Leukemia. 2007;21:2527-2536. (Pubitemid 350148897)
38. Caldwell GM, Jones C, Gensberg K, et al. The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res. 2004;64:883-888. (Pubitemid 38176888)
39. Fukui T, Kondo M, Maeda O, et al. Transcriptional silencing of secreted frizzled related protein 1 (SFRP1) by promoter hypermethylation in non-small-cell lung cancer. Oncogene. 2005;24:6323-6327. (Pubitemid 43080055)
40. Horvath LG, Henshall SM, Kench JG, et al. Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro. Clin Cancer Res. 2004;10:615-625.
41. Carmon KS, Loose DS. Secreted frizzled-related protein 4 regulates 2 wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells. Mol Cancer Res. 2008;6:1017-1028.
42. Lee EJ, Jo M, Rho SB, et al. Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin. Int J Cancer. 2009;124:287-297.
43. Ng PC, Henikoff S. Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet. 2006;7:61-80. (Pubitemid 44627922)
44. Giachino DF, Ghio P, Regazzoni S, et al. Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer. Clin Cancer Res. 2007;13:2876-2881. (Pubitemid 46849561)
45. Berndt SI, Huang WY, Fallin MD, et al. Genetic variation in base excision repair genes and the prevalence of advanced colorectal adenoma. Cancer Res. 2007;67:1395-1404.
46. Shen LX, Basilion JP, Stanton VP Jr. Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc Natl Acad Sci U S A. 1999;96:7871-7876.
47. Duan J, Wainwright MS, Comeron JM, et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet. 2003;12:205-216. (Pubitemid 36204418)
48. Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM. Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer. Cancer Res. 2007;67:9609-9612. (Pubitemid 47621204)
49. Holt SK, Karyadi DM, Kwon EM, Stanford JL, Nelson PS, Ostrander EA. Association of megalin genetic polymorphisms with prostate cancer risk and prognosis. Clin Cancer Res. 2008;14:3823-3831.
50. Costa BM, Ferreira P, Costa S, et al. Association between functional EGF+61 polymorphism and glioma risk. Clin Cancer Res. 2007;13:2621-2626. (Pubitemid 46788028)